Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2981)
All Articles published online
|
Apr 7, 2006 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hiraoka A, Kumagi T, Hirooka M, Uehara T, Kurose K, Iuchi H, Hiasa Y, Matsuura B, Michitaka K, Kumano S, Tanaka H, Yamashita Y, Horiike N, Mochizuki T, Onji M. Prognosis following transcatheter arterial embolization for 121 patients with unresectable hepatocellular carcinoma with or without a history of treatment. World J Gastroenterol 2006; 12(13): 2075-2079 [PMID: 16610060 DOI: 10.3748/wjg.v12.i13.2075] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i13/2075.htm |
| Number | Citing Articles |
| 1 |
Mirko Olivo, Franco Valenza, Antonio Buccellato, Lorenza Scala, Roberto Virdone, Elio Sciarrino, Sonia Di Piazza, Ciro Marrone, Ambrogio Orlando, Giorgio Fusco, Salvatore Madonia, Mario Cottone. Transcatheter arterial chemoembolisation for hepatocellular carcinoma in cirrhosis: Survival rate and prognostic factors. Digestive and Liver Disease 2010; 42(7): 515 doi: 10.1016/j.dld.2009.09.012
|
| 2 |
Atsushi Hiraoka, Takashi Kumada, Kazuhiro Nouso, Kunihiko Tsuji, Ei Itobayashi, Masashi Hirooka, Kazuya Kariyama, Toru Ishikawa, Hidenori Toyoda, Toshifumi Tada, Yoichi Hiasa, Kojiro Michitaka. Simple method with tumor markers for predicting prognosis following transcatheter arterial chemo-embolization for switching to next therapy in intermediate hepatocellular carcinoma: multi-center analysis. Kanzo 2017; 58(6): 329 doi: 10.2957/kanzo.58.329
|
| 3 |
Li Chen, Chen-Xi Yu, Bin-Yan Zhong, Hai-Dong Zhu, Zhi-Cheng Jin, Guang-Yu Zhu, Qi Zhang, Cai-Fang Ni, Gao-Jun Teng. Development of TACE Refractoriness Scores in Hepatocellular Carcinoma. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.615133
|
| 4 |
Wen-Sheng Tzeng, Reng-Hong Wu, Shih-Chin Chang, Chung-Kuao Chou, Ching-Yih Lin, Jyh-Jou Chen, Shun-Chun Yang, Chi-Hung Lin. Ionic Versus Nonionic Contrast Media Solvents Used with an Epirubicin-based Agent for Transarterial Chemoembolization of Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 2008; 19(3): 342 doi: 10.1016/j.jvir.2007.10.021
|
| 5 |
Atsushi Hiraoka, Takashi Kumada, Kazuya Kariyama, Hidenori Toyoda, Satoshi Yasuda, Kunihiko Tsuji, Takeshi Hatanaka, Satoru Kakizaki, Atsushi Naganuma, Toru Ishikawa, Toshifumi Tada, Koichi Takaguchi, Ei Itobayashi, Noritomo Shimada, Hiroshi Shibata, Takaaki Tanaka, Akemi Tsutsui, Takuya Nagano, Michitaka Imai, Shinichiro Nakamura, Kazuhiro Nouso. Simple Scoring System for Predicting TACE Unsuitable among Intermediate-Stage Hepatocellular Carcinoma Patients in the Multiple Systemic Treatment Era. Oncology 2022; 100(2): 65 doi: 10.1159/000520292
|
| 6 |
Atsushi Hiraoka, Kojiro Michitaka, Norio Horiike, Satoshi Hidaka, Takahide Uehara, Soichi Ichikawa, Aki Hasebe, Yasunao Miyamoto, Tomoyuki Ninomiya, Ichiro Sogabe, Yoshihiro Ishimaru, Hideki Kawasaki, Yohei Koizumi, Masashi Hirooka, Yoshimasa Yamashita, Masanori Abe, Yoichi Hiasa, Bunzo Matsuura, Morikazu Onji. Radiofrequency ablation therapy for hepatocellular carcinoma in elderly patients. Journal of Gastroenterology and Hepatology 2010; 25(2): 403 doi: 10.1111/j.1440-1746.2009.06037.x
|
| 7 |
Jay L. Grosfeld, Jean-Bernard Otte. The Surgery of Childhood Tumors. 2008; : 227 doi: 10.1007/978-3-540-29734-5_12
|
| 8 |
Stephen L Chan, Anthony TC Chan, Winnie Yeo. Role of α-Fetoprotein in Hepatocellular Carcinoma: Prognostication, Treatment Monitoring or Both?. Future Oncology 2009; 5(6): 889 doi: 10.2217/fon.09.64
|
| 9 |
Zhongxiang Du, Qi Zhang, Jie Yang. Prognostic related gene index for predicting survival and immunotherapeutic effect of hepatocellular carcinoma. Medicine 2023; 102(44): e35820 doi: 10.1097/MD.0000000000035820
|
| 10 |
Junhui Yang, Yunjie Zhang, Yifan Kong, Jiawei Lin, Guoqing Zhu, Hao Zhang, Zhijie Yu, Pixu Liu, Jinglin Xia. Diagnostic value of serum inflammatory markers in predicting early refractoriness of transarterial chemoembolization in patients with Barcelona Clinic Liver Cancer Stage 0, A, and B hepatocellular carcinoma. Brazilian Journal of Medical and Biological Research 2024; 57 doi: 10.1590/1414-431x2024e13661
|
| 11 |
ATSUSHI HIRAOKA, MISA ICHIRYU, NAYU TAZUYA, HIRONORI OCHI, ATSUSHI TANABE, HIROMASA NAKAHARA, SATOSHI HIDAKA, TAKAHIDE UEHARA, SOICHI ICHIKAWA, AKI HASEBE, YASUNAO MIYAMOTO, TOMOYUKI NINOMIYA, MASASHI HIROOKA, MASANORI ABE, YOICHI HIASA, BUNZO MATSUURA, MORIKAZU ONJI, KOJIRO MICHITAKA. Clinical translation in the treatment of hepatocellular carcinoma following the introduction of contrast-enhanced ultrasonography with Sonazoid. Oncology Letters 2010; 1(1): 57 doi: 10.3892/ol_00000010
|
| 12 |
Jie Peng, Shuai Kang, Zhengyuan Ning, Hangxia Deng, Jingxian Shen, Yikai Xu, Jing Zhang, Wei Zhao, Xinling Li, Wuxing Gong, Jinhua Huang, Li Liu. Residual convolutional neural network for predicting response of transarterial chemoembolization in hepatocellular carcinoma from CT imaging. European Radiology 2020; 30(1): 413 doi: 10.1007/s00330-019-06318-1
|